SCHEDULE 13G

Company

IGC Pharma, Inc.

Filed

April 22, 2015

Accession Number

0001387131-15-001369

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →